SK

Sudhir Kumar Sahu

Active Director Director DIN 11022847
DIN 11022847 First appointment Mar 2025 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value •••• Premium profile

About Sudhir Kumar Sahu

Data last updated:

Sudhir Kumar Sahu is a Director at Jetansh Pharmaceuticals Private Limited (since 2025). The company operates in Chemicals. Jetansh Pharmaceuticals Private Limited reported revenue of ₹24,661 (FY 2022).

DIN 11022847
Primary Designation Director
Industry Chemicals
First Appointment 26 Mar 2025
Oldest Company Age 7 yrs
Largest company Jetansh Pharmaceuticals Private Limited · ₹24,661 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Mar 20252019₹24,661 (FY 2022)Active

Board colleagues of Sudhir Kumar Sahu

Directorship timeline

Open interactive timeline →
Jetansh Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sudhir Kumar Sahu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Kumar Sahu

Sudhir Kumar Sahu currently holds 1 directorship: Jetansh Pharmaceuticals Private Limited (Director, since 26 Mar 2025, revenue ₹24,661 (FY 2022)).

Sudhir Kumar Sahu was first appointed on 26 Mar 2025 as Director at Jetansh Pharmaceuticals Private Limited.

The current boards of Sudhir Kumar Sahu's companies include Abhishek Jaitly (Jetansh Pharmaceuticals Private Limited), Anuj Kumar (Jetansh Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available